A case series of adrenoleukodystrophy in children conceived through in vitro fertilization with an egg donor.
ALD
Adrenoleukodystrophy
case report
genetic testing
in vitro fertilization
Journal
F&S reports
ISSN: 2666-3341
Titre abrégé: F S Rep
Pays: United States
ID NLM: 101766618
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
03
08
2022
revised:
15
11
2022
accepted:
16
12
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
To report 3 cases of adrenoleukodystrophy (ALD) in children conceived by in vitro fertilization (IVF) and egg donation. A case report. Patients aged 4-5 years old, evaluated by the University of Minnesota Leukodystrophy Center, who were diagnosed with ALD after being conceived by IVF with oocytes provided by the same donor. One patient received a hematopoietic stem cell transplant from a human leukocyte antigen-matched donor, and 1 patient received autologous lentiviral corrected hematopoietic cells. The disease state in 1 patient was unfortunately too advanced for effective treatment to be administered. Progression of disease after diagnosis or treatment was observed by cerebral magnetic resonance imaging and monitoring the development or advancement of any cognitive, adaptive, and motor deficits. Patients who received a transplant for ALD successfully experienced little to no disease progression at least 6 months to 1 year after treatment. These 3 cases of transmission of ALD through oocyte donation and IVF highlight the potential need to implement more comprehensive genetic screening of gamete donors to prevent the transfer of rare but severe genetic diseases through IVF. Further, these cases highlight limitations in carrier screening guidelines that limit reportable variants to pathogenic and likely pathogenic variants.
Identifiants
pubmed: 36959964
doi: 10.1016/j.xfre.2022.12.005
pii: S2666-3341(22)00142-8
pmc: PMC10028476
doi:
Types de publication
Journal Article
Langues
eng
Pagination
24-28Informations de copyright
© 2022 The Author(s).
Références
Endocr Pract. 2014 Jul;20(7):e126-9
pubmed: 24641931
Genet Med. 2020 Aug;22(8):1288-1295
pubmed: 32404922
Eur J Pediatr. 2003 Jan;162(1):6-14
pubmed: 12486501
Fertil Steril. 2021 Jun;115(6):1395-1410
pubmed: 33838871
Curr Opin Immunol. 2008 Oct;20(5):588-93
pubmed: 18674615
Cells. 2022 Jan 14;11(2):
pubmed: 35053399
Ann Neurol. 2001 Apr;49(4):512-7
pubmed: 11310629
AJNR Am J Neuroradiol. 2016 Feb;37(2):367-72
pubmed: 26427835
Orphanet J Rare Dis. 2012 Aug 13;7:51
pubmed: 22889154
Endocr Rev. 2020 Aug 1;41(4):
pubmed: 32364223
Fertil Steril. 2010 Feb;93(3):1006.e1-2
pubmed: 19962137
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Hum Reprod. 2021 May 17;36(6):1702-1710
pubmed: 33842976
Blood. 2004 Aug 1;104(3):881-8
pubmed: 15073029
Genet Med. 2021 Oct;23(10):1793-1806
pubmed: 34285390
Lancet. 2000 Aug 26;356(9231):713-8
pubmed: 11085690
Brain. 2014 Mar;137(Pt 3):693-706
pubmed: 24480483
N Engl J Med. 2017 Oct 26;377(17):1630-1638
pubmed: 28976817
J Family Reprod Health. 2021 Jun;15(2):130-135
pubmed: 34721603